Literature DB >> 4260944

Bovine vibriosis: the distribution and specificity of antibodies induced by vaccination and infection and the immunofluorescent localization of the organism in infected heifers.

B N Wilkie, A J Winter.   

Abstract

Two groups of three Holstein heifers were immunized respectively with Vibrio fetus venerealis and Vibrio fetus intestinalis incorporated in Freund's complete adjuvant. Both serum and vaginal mucus agglutination titers increased following immunization. Vaginal mucus samples were more frequently positive when the homologous cells were used as antigen in the agglutination test. Ten non-immunized heifers were inoculated with another strain of V. fetus venerealis and slaughtered at periods of 30 to 40 and 60 to 70 days post-inoculation (DPI). Agglutinating antibodies were present in the vaginal mucus of some infected individuals by five weeks post-inoculation. In the course of the experiment 11 vaginal mucus samples were obtained which agglutinated heated cells of the infecting strain; one aggglutinated whole cells. Precipitins toward homologous antigens could not be demonstrated in vaginal mucus but four of six samples tested precipitated a heat stable extract from an intestinal strain of the same O-serotype. Bacterial antigen was detected by immunofluorescence on the surface, as well as within and beneath the epithelium at all levels of the reproductive tract regardless of time of slaughter. Lesions in infected animals consisted of focal and diffuse lymphocytosis, plasmacytosis, and epithelial vacuolation. Diffuse neutrophilic infiltration of the oviducts was observed. Agglutinins appeared in the serum of each of nine heifers immunized with whole cells of same venereal strain. Group mean serum titers for whole and heated cells were 1/28,000 and 1/1,300 respectively. Vaginal mucus samples agglutinated whole cells in 48% of tests while 6.3% reacted with heated cells. Serum, but not vaginal mucus, of immunized animals precipitated soluble antigens of the immunizing strain. The immunizing strain of V. fetus did not infect the reproductive tract of any of six immunized heifers upon challenge.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4260944      PMCID: PMC1319587     

Source DB:  PubMed          Journal:  Can J Comp Med        ISSN: 0008-4050


  23 in total

1.  ARTIFICIAL STIMULATION OF RESISTANCE TO BOVINE VIBRIOSIS.

Authors:  A B HOERLEIN; T KRAMER
Journal:  Am J Vet Res       Date:  1963-09       Impact factor: 1.156

2.  BOVINE VIBRIOSIS IMMUNIZATION.

Authors:  A B HOERLEIN; E J CARROLL; T KRAMER; W H BECKENHAUER
Journal:  J Am Vet Med Assoc       Date:  1965-04-15       Impact factor: 1.936

3.  A study of the diagnosis of bovine vibriosis with special reference to the detection of agglutinins in the vaginal secretions.

Authors:  D E HUGHES
Journal:  Cornell Vet       Date:  1953-07

4.  Immune response to genital infections.

Authors:  B N Wilkie; J R Duncan; A J Winter
Journal:  J Dairy Sci       Date:  1971-09       Impact factor: 4.034

5.  Evaluation of a new trivalent bovine vibriosis bacterin using fluorescent antibody technic.

Authors:  G J Lincoln; K J Trout
Journal:  Vet Med Small Anim Clin       Date:  1967-06

6.  Experimental Vibrio fetus (venerealis) infection in heifers. The immunising properties of killed organisms injected subcutaneously.

Authors:  B L Clark; J H Dufty; M J Monsbourgh
Journal:  Aust Vet J       Date:  1968-03       Impact factor: 1.281

7.  Duration of immunity to bovine genital vibrosis.

Authors:  A B Hoerlein; E J Carroll
Journal:  J Am Vet Med Assoc       Date:  1970-03-15       Impact factor: 1.936

8.  Protective antigens of Vibrio fetus in sheep.

Authors:  R L Berg; B D Firehammer; W W Hawkins
Journal:  Am J Vet Res       Date:  1969-08       Impact factor: 1.156

9.  Serologic response of heifers vaccinated and exposed to vibriosis.

Authors:  T Kramer; A B Hoerlein
Journal:  Am J Vet Res       Date:  1969-07       Impact factor: 1.156

10.  Characterization of the antibody for Vibrio fetus endotoxin in sera of normal and V. fetus infected cattle.

Authors:  A J Winter
Journal:  J Immunol       Date:  1965-12       Impact factor: 5.422

View more
  9 in total

1.  [Immunofluorescent demonstration of casein and beta-lactoglobulin synthesis in the bovine mammary gland].

Authors:  U Kihm
Journal:  Histochemie       Date:  1973-05-30

2.  Bovine veneral vibriosis: cure of genital infection in females by systemic immunization.

Authors:  G G Schurig; C E Hall; L B Corbell; J R Duncan; A J Winter
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

3.  Immunoglobulin classes in genital secretions of mycoplasma-infected and normal heifers.

Authors:  L B Corbeil; C E Hall; D Lein; R R Corbeil; J R Duncan
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

4.  The association between antibody titres against Campylobacter fetus and reproductive efficiency in dairy cattle.

Authors:  S Akhtar; H P Riemann; M C Thurmond; C E Franti
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

5.  Bovine venereal vibriosis: variations in immunoglobulin class of antibodies in genital secretions and serum.

Authors:  L B Corbeil; J R Duncan; G G Schurig; C E Hall; A J Winter
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

6.  Natural and immune antibodies for Vibrio fetus in serum and secretions of cattle.

Authors:  J R Duncan; B N Wilkie; A J Winter
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

Review 7.  Bovine campylobacteriosis: a review.

Authors:  M A Hoffer
Journal:  Can Vet J       Date:  1981-11       Impact factor: 1.008

8.  Immunoglobulin classes and biological functions of Campylobacter (Vibrio) fetus antibodies in serum and cervicovaginal mucus.

Authors:  L B Corbeil; G D Schurig; J R Duncan; R R Corbeil; A J Winter
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

Review 9.  Vaccines produced by conventional means to control major infectious diseases of man and animals.

Authors:  J L Bittle; S Muir
Journal:  Adv Vet Sci Comp Med       Date:  1989
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.